Clinical Trials Browser

reolysin × Gastrointestinal × 1 year × Clear all

NCT07280377 2026-05-19

GOBLET

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

NCT07446322 2026-05-05

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Ras-mutated Metastatic Colorectal Cancer